Results 291 to 300 of about 1,198,663 (392)
Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management. [PDF]
Front OncolPark YH, Lee SC, Singer CF, Balmaña J, Dent RA, Tan VK, Mulansari NA, Yusof MM, Que FVF, Lu YS, Parinyanitikul N, Pham CP, Taib NA, Kong SY, Antill Y, Kim HJ. +15 moreeuropepmc +1 more sourceStimuli‐Responsive Low‐Frequency Terahertz Absorption ON‐OFF Switchability in Spin‐Crossover Material
Advanced Materials, EarlyView.A switchable Fe(II)–Hg(II) coordination polymer exhibits reversible ON‐OFF terahertz (THz) absorption through temperature‐ and light‐induced spin‐crossover. The material shows strong, tunable THz responses linked to phonon modes around Fe(II) centers, supported by spectroscopic measurements and calculations.Guanping Li, Olaf Stefanczyk, Kunal Kumar, Laurent Guérin, Kazuki Nakamura, Maryam Alashoor, Lulu Xiong, Koji Nakabayashi, Kenta Imoto, Yuiga Nakamura, Sumit Ranjan Maity, Guillaume Chastanet, Nicholas F. Chilton, Shin‐ichi Ohkoshi +13 morewiley +1 more sourceReengineering Endogenous Targeting Lipid Nanoparticles (ENDO) for Systemic Delivery of mRNA to Pancreas
Advanced Materials, EarlyView.ENDO lipid nanoparticles containing cholecalciferol as a fifth component demonstrate mRNA delivery to the pancreas with 99% selectivity, including beta cells. This platform shows minimal toxicity and sustained protein expression for up to 3 days in a dose‐dependent manner, offering a novel approach to pancreas‐specific mRNA delivery and gene therapy ...Ivan Isaac, Luv Patel, Nguyen Tran, Amarnath Singam, DongSoo Yun, Prasun Guha, Seungman Park, Chandrabali Bhattacharya +7 morewiley +1 more sourceNanoparticle design to induce tumor immunity and challenge the suppressive tumor microenvironment [PDF]
, 2014 Ali, Ali, Alnemri, Alshamsan, Anguille, Apetoh, Badie, Bal, Banciu, Becker, Belizaire, Benteyn, Blander, Bonehill, Breckpot, Broderick, Casares, Chang, Chiang, Clowes, Coley, Coulie, Cubillos-Ruiz, de Vries, Demento, Dominguez, Emeagi, Emeagi, Fernandez, Fischer, Fischer, Franklin, Gabrilovich, Giddam, Gooden, Gross, Gunzer, Haen, Hamzah, Harris, Heleen Dewitte, Henri, Hess, Hobbs, Hu, Huang, Huang, Huang, Humphries, Ilyinskii, Ine Lentacker, Ito, Jasani, Johansen, Kadowaki, Karine Breckpot, Kasturi, Kawakami, Kerkar, Kroemer, Kwong, Lake, Lakhani, Larocca, Larsson, Lee, Lee, Leuschner, Li, Li, Li, Liao, Lin, Lu, Luo, Lutz, Ma, Mantovani, Marchini, Matsumura, Matzinger, Matzinger, Melhem, Milicic, Moon, Motz, Mueller, Mukai, Nguyen, Nomura, Nordly, Nowak, Pardoll, Park, Perche, Perrie, Prabhakar, Pradere, Pradhan, Prasad, Puig-Kroger, Qin, Ray, Rein Verbeke, Rizwan, Roy, Roy, Sato, Schlosser, Schouppe, Sharp, She, Shimizu, Shortman, Simpson-Abelson, Singh, Singh, Slutter, Small, Smits, Stano, Stefaan C. De Smedt, Steinman, Su, Tacken, Tang, Tang, Tao, Temming, Thambi, van den Boorn, van der Most, Van Nuffel, Vanderbruggen, Villadangos, Villadangos, Vinogradov, Wang, Warburg, Wayteck, Wei, Wimmers, Wingender, Wong, Wydra, Yanasarn, Yoshizaki, Yu, Zaks, Zeisberger, Zhang, Zhao, Zhou, Zinkernagel +153 morecore +2 more sources11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial
The Lancet, 2017 D. Cameron, M. Piccart-Gebhart, R. Gelber, M. Procter, A. Goldhirsch, E. Azambuja, G. Castro, M. Untch, I. Smith, L. Gianni, J. Baselga, N. Al-Sakaff, S. Lauer, E. McFadden, B. Leyland-Jones, R. Bell, M. Dowsett, C. Jackisch +17 moresemanticscholar +1 more sourceAdjuvant Activities in Production of Reaginic Antibody by Bacterial Cell Wall Peptidoglycan or Synthetic N -Acetylmuramyl Dipeptides in Mice
, 1979 Hisashi Ohkuni, Yoshihiko Norose, Midori Ohta, Masaaki Hayama, Yoshitami Kimura, Masaya Tsujimoto, Shozo Kotani, Tetsuo Shiba, Shoichi Kusumoto, Kanae Yokogawa, Shigeo Kawata +10 moreopenalex +1 more source
